- Home
- MRUS vs APPN Comparison
MRUS vs APPN Comparison
Compare MRUS & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- APPN
- Stock Information
- Founded
- MRUS 2003
- APPN 1999
- Country
- MRUS Netherlands
- APPN United States
- Employees
- MRUS N/A
- APPN N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- APPN Computer Software: Prepackaged Software
- Sector
- MRUS Health Care
- APPN Technology
- Exchange
- MRUS Nasdaq
- APPN Nasdaq
- Market Cap
- MRUS 2.7B
- APPN 2.3B
- IPO Year
- MRUS 2016
- APPN 2017
- Fundamental
- Price
- MRUS $43.06
- APPN $26.55
- Analyst Decision
- MRUS Strong Buy
- APPN Hold
- Analyst Count
- MRUS 13
- APPN 7
- Target Price
- MRUS $86.85
- APPN $34.00
- AVG Volume (30 Days)
- MRUS 872.0K
- APPN 624.1K
- Earning Date
- MRUS 05-07-2025
- APPN 05-08-2025
- Dividend Yield
- MRUS N/A
- APPN N/A
- EPS Growth
- MRUS N/A
- APPN N/A
- EPS
- MRUS N/A
- APPN N/A
- Revenue
- MRUS $36,133,000.00
- APPN $617,022,000.00
- Revenue This Year
- MRUS $26.81
- APPN $12.67
- Revenue Next Year
- MRUS $23.85
- APPN $10.86
- P/E Ratio
- MRUS N/A
- APPN N/A
- Revenue Growth
- MRUS N/A
- APPN 13.14
- 52 Week Low
- MRUS $33.19
- APPN $24.00
- 52 Week High
- MRUS $61.61
- APPN $43.33
- Technical
- Relative Strength Index (RSI)
- MRUS 51.15
- APPN 38.08
- Support Level
- MRUS $33.19
- APPN $26.14
- Resistance Level
- MRUS $43.46
- APPN $27.94
- Average True Range (ATR)
- MRUS 3.53
- APPN 1.53
- MACD
- MRUS 0.34
- APPN 0.01
- Stochastic Oscillator
- MRUS 80.53
- APPN 42.29
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About APPN Appian Corporation
Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.